2018/06/05（火）
Pitch 1-4: Yasumasa Goh, Beacle Inc.
Dr. Go will pitch in Pitch Session 1!
郷氏はPitch Session 1に登壇予定！
| Pitch Title |
Preventive and therapeutic vaccine against Hepatitis B using a novel HBs-L antigen |
| Speaker |
Yasumasa Goh President and CEO, Beacle Inc. 郷 保正 氏 ㈱ビークル 代表取締役社長 |
|
Speaker Profile |
After 25 years experience in drug discovery and development in Shionogi, Yasumasa Goh has moved to Nagahama Institute of Biotechnology as a professor, and then joined Beacle Inc as CEO. |
Notice
HVC KYOTO 2018 will be held on July 3rd 2018!
Click here for the program.
To attend the event, please fill out the form from here!
ご案内
HVC KYOTO 2018は2018/7/3に開催いたします。
当日のプログラムは こちら をご覧ください。
HVC KYOTO 2018への参加お申し込みは こちら から。
